Kular, Lara <br/><br/>
NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9.  [electronic resource] 

 -  Journal of neuroinflammation  Feb 2012 
 - 36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1742-2094 
<br/><br/><label>Standard No.: </label>10.1186/1742-2094-9-36  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Cells, Cultured<br/>Chemokine CCL2--metabolism<br/>Dexamethasone--pharmacology<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Freund's Adjuvant<br/>Ganglia, Spinal--cytology<br/>Gene Expression Regulation--drug effects<br/>Hyperalgesia--chemically induced<br/>Immediate-Early Proteins--genetics<br/>Inflammation--chemically induced<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Male<br/>Matrix Metalloproteinase 2--genetics<br/>Matrix Metalloproteinase 9--metabolism<br/>Nerve Tissue Proteins--metabolism<br/>Pain--drug therapy<br/>Pain Measurement<br/>Pain Threshold--drug effects<br/>RNA, Messenger--metabolism<br/>RNA, Small Interfering--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sensory Receptor Cells--drug effects<br/>Spinal Cord--pathology<br/>Time Factors<br/>Transfection<br/>Up-Regulation--drug effects